Teladoc Health schedules October 28 results and Teladoc Health stock trades at EUR 5.18
Published on 10/15/2026 at 12:37 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSScheduled events and operating pressure
- Teladoc Health announced its October 28, 2026 results date on October 14, 2026.
- Second-quarter 2026 revenue fell 4.00 percent to USD 606.90 million.
- Teladoc Health stock traded at EUR 5.18 at 12:30 p.m. CEST at Lang & Schwarz on October 15, 2026.
Teladoc Health (ISIN US87918A1051) has scheduled its third-quarter 2026 results for October 28, 2026, giving investors a near-term test of a business that posted USD 606.90 million in second-quarter revenue. Stockwatch reported the date on October 14, 2026.
Three events shape the story
On September 25, 2026, Teladoc Health announced that Jonathan Dorfman would become chief legal officer and secretary on November 2, 2026, according to Teladoc Health. On October 7, 2026, the company introduced SoloVitals and SoloScribe, with Solo installed in more than 15,000 care locations globally, according to its official release. The October 14, 2026 results announcement is the latest event in that sequence.
What will results test?
The earnings release will put the AI expansion beside recent operating pressure. MarketBeat reported that second-quarter revenue fell 4.00 percent year over year to USD 606.93 million, while adjusted earnings per share were a loss of USD 0.21, better than the USD 0.25 consensus loss. The same report said third-quarter 2026 guidance covered an adjusted earnings-per-share loss of USD 0.30 to USD 0.20.
Analyst positioning remains divided rather than uniformly bullish. MarketBeat reported 16 brokerage ratings consisting of five Buys, 10 Holds and one Sell, with an average 12-month target of USD 7.54 on October 14, 2026. That target is a separate US-dollar reference and is not combined with the euro quotation.
Next reporting date is set
The next substantiated company date is October 28, 2026, when Teladoc Health plans to release third-quarter results after the US market close and hold its conference call at 5:00 p.m. ET, according to Stockwatch.
Stock stays tied to execution
The upcoming report must show whether the new Solo capabilities can support enterprise growth while the broader revenue base remains under pressure.
Teladoc Health was trading at EUR 5.18 at Lang & Schwarz on October 15, 2026 at 12:30 p.m. CEST.
The further course of trading is shown by the continuously updated real-time quote of Teladoc Health stock.
Teladoc Health stock facts
- Company: Teladoc Health, Inc.
- ISIN: US87918A1051
- Ticker: TDOC
- Primary exchange: NYSE
- Price Lang & Schwarz (as of October 15, 2026, 12:30 p.m. CEST): EUR 5.18
- Market capitalization: USD 1.1 billion (as of October 14, 2026)
- Sector / Industry: Healthcare / Medical - Healthcare Information Services
Market context: Market report S&P 500.
